• Home
  •  / Laboratory Corporation of America Holdings

Laboratory Corporation of America Holdings

OverviewSuggest Edit

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company. It offers a range of clinical laboratory tests used by hospitals, physicians and other healthcare providers and commercial clients to assist in the diagnosis, monitoring and treatment of diseases and medical conditions through the examination of substances in blood, tissues, and other specimens. The Company also provides specialty testing services in the areas of women's health, allergy, diagnostic genetics, cardiovascular disease, infectious disease, endocrinology, oncology, coagulation, pharmacogenetics, toxicology, medical drug monitoring, and pain management, as well as esoteric testing, cancer diagnostics, and other complex procedures. In addition, it provides drug development solutions and laboratory testing services.

TypePublic
Founded1976
HQBurlington, USMap
Websitelabcorp.com
View Jobs (1,520)

Recent NewsAll News

Latest Updates

Employees (est.) (Dec 2018)61,000(+2%)
Job Openings1,520
Revenue (FY, 2019)$11.6 B(+2%)
Share Price (Sept 2020)$184.1 (+2%)
Cybersecurity ratingBMore

Key People/Management at Laboratory Corporation of America Holdings

David P. King

David P. King

Chairman and Chief Executive Officer
Glenn A. Eisenberg

Glenn A. Eisenberg

Executive Vice President and Chief Financial Officer
Lance V. Berberian

Lance V. Berberian

Senior Vice President and Chief Information Officer
Lisa J. Uthgenannt

Lisa J. Uthgenannt

Chief Human Resources Officer
Show more

Laboratory Corporation of America Holdings Office Locations

Laboratory Corporation of America Holdings has an office in Burlington
Burlington, US (HQ)
531 S Spring St
Show all (1)

Laboratory Corporation of America Holdings Financials and Metrics

Laboratory Corporation of America Holdings Revenue

Embed Graph
View revenue for all periods
Laboratory Corporation of America Holdings's revenue was reported to be $11.55 b in FY, 2019
USD

Revenue (Q2, 2020)

2.8b

Gross profit (Q2, 2020)

760.5m

Gross profit margin (Q2, 2020), %

27.5%

Net income (Q2, 2020)

231.6m

EBIT (Q2, 2020)

297.7m

Market capitalization (28-Sept-2020)

17.9b

Closing stock price (28-Sept-2020)

184.1
Laboratory Corporation of America Holdings's current market capitalization is $17.9 b.
Annual
USDFY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

5.0b5.5b5.7b5.8b6.0b8.5b9.4b10.2b11.3b11.6b

Revenue growth, %

4%44%11%

Cost of goods sold

2.9b3.3b3.4b3.6b3.8b5.6b6.3b6.7b8.2b8.3b

Gross profit

2.1b2.3b2.2b2.2b2.2b2.9b3.2b3.5b3.2b3.3b
Quarterly
USDQ1, 2010Q2, 2010Q3, 2010Q1, 2011Q2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Revenue

1.2b1.2b1.3b1.4b1.4b1.4b1.4b1.4b1.4b1.4b1.5b1.5b1.4b1.5b1.6b1.8b2.2b2.3b2.3b2.4b2.4b2.4b2.5b2.6b2.8b2.9b2.8b2.8b2.9b2.9b2.8b2.8b

Cost of goods sold

686.7m704.8m748.8m800.0m815.1m836.0m847.2m843.9m863.3m868.7m890.9m914.6m913.9m947.8m980.6m1.2b1.4b1.5b1.5b1.6b1.6b1.6b1.6b1.7b2.1b2.0b2.0b2.0b2.1b2.1b2.1b2.0b

Gross profit

506.9m533.6m527.7m568.4m588.2m568.5m576.1m579.5m556.1m572.2m577.3m547.6m516.8m568.6m571.2m596.0m774.6m762.9m777.3m826.8m788.4m803.6m861.8m882.8m779.0m835.1m789.9m789.7m824.8m817.3m728.0m760.5m

Gross profit Margin, %

42%43%41%42%42%40%40%41%39%40%39%37%36%37%37%34%35%34%34%35%33%33%34%34%27%29%28%28%29%28%26%27%
show all
Annual
USDFY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

230.7m159.3m466.8m404.0m580.0m716.4m433.6m316.7m426.8m337.5m

Accounts Receivable

655.6m699.8m718.5m784.7m815.7m1.2b1.3b1.5b1.5b1.5b

Prepaid Expenses

95.7m79.6m74.6m157.5m340.3m321.2m421.4m309.0m373.7m

Inventories

103.4m110.8m121.0m136.5m139.5m191.0m205.2m227.6m237.3m244.7m
Quarterly
USDQ1, 2010Q2, 2010Q3, 2010Q1, 2011Q2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Cash

172.2m103.8m96.9m195.4m118.9m85.8m129.9m124.4m466.0m185.8m111.3m174.1m338.9m479.5m575.7m446.4m619.0m713.0m696.3m639.6m567.6m365.5m299.9m409.3m361.8m221.4m892.6m348.8m265.4m361.1m323.6m

Accounts Receivable

614.3m617.6m631.0m717.3m714.8m718.7m751.7m735.8m768.9m793.8m815.7m813.2m822.0m832.6m841.6m1.2b1.2b1.2b1.3b1.3b1.3b1.4b1.4b1.6b1.6b1.5b1.5b1.6b1.6b1.6b1.5b

Prepaid Expenses

74.3m69.0m68.7m71.8m64.4m78.4m69.8m68.1m78.2m67.4m75.3m79.9m125.2m115.2m126.3m319.8m387.3m378.3m360.1m297.2m325.6m343.1m379.3m450.2m347.0m286.1m292.5m317.1m298.6m297.7m353.2m317.5m

Inventories

82.5m86.3m88.2m98.0m106.8m103.8m107.0m114.0m118.9m124.0m126.4m126.5m134.8m134.5m138.8m186.5m182.0m181.6m188.2m189.6m198.8m199.8m209.9m217.2m226.2m230.7m233.0m233.7m219.7m234.9m342.3m
show all
Annual
USDFY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Net Income

558.2m519.7m583.1m575.4m512.6m438.0m733.2m1.3b883.9m824.9m

Depreciation and Amortization

203.6m231.4m229.8m245.5m457.8m499.2m552.1m577.2m

Inventories

5.8m(6.1m)(6.3m)(15.3m)(300.0k)(200.0k)(9.6m)(16.4m)(18.9m)(21.9m)

Accounts Payable

50.1m(8.7m)(30.0m)60.8m(21.2m)30.7m(8.7m)85.6m43.3m(12.8m)
Quarterly
USDQ1, 2010Q2, 2010Q3, 2010Q1, 2011Q2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Net Income

136.2m286.4m426.4m127.1m250.0m384.3m161.6m314.9m462.9m147.2m299.2m448.7m113.5m255.2m392.7m1.0m170.3m323.5m160.2m359.0m548.6m192.5m381.4m564.8m172.5m406.6m725.7m185.9m376.6m597.6m(316.9m)

Depreciation and Amortization

50.0m100.1m150.7m58.1m115.9m173.6m56.7m112.8m170.4m55.5m112.4m170.3m60.7m123.5m182.0m104.7m223.1m344.5m122.4m247.8m368.9m128.1m255.1m388.2m142.8m281.3m414.4m137.3m277.1m421.4m144.6m

Inventories

(7.7m)(3.8m)(2.3m)(5.6m)2.7m(900.0k)3.9m(3.3m)(4.3m)(3.2m)(5.7m)(5.6m)2.9m3.4m(1.3m)4.2m9.5m9.6m2.4m600.0k(4.8m)4.9m(700.0k)(6.4m)1.4m(4.7m)(8.8m)3.4m(1.7m)(14.5m)(10.6m)

Accounts Payable

(14.8m)9.1m(8.9m)(42.6m)(57.3m)(40.8m)(32.3m)(23.3m)(19.4m)10.1m16.9m25.2m(27.1m)(25.7m)(16.2m)(48.9m)(33.8m)(24.3m)(34.1m)(54.3m)(56.3m)(28.0m)(29.0m)29.6m(59.8m)(91.3m)(79.9m)(28.8m)(28.2m)(56.5m)
show all
USDQ1, 2010

Financial Leverage

2.3 x
Show all financial metrics

Laboratory Corporation of America Holdings Operating Metrics

FY, 2016

Countries

60

Patient Service Centers

1.75 k
Show all operating metrics

Laboratory Corporation of America Holdings Cybersecurity Score

Cybersecurity ratingPremium dataset

B

83/100

Learn more about about our premium products
SecurityScorecard logo

Laboratory Corporation of America Holdings Revenue Breakdown

Embed Graph

Laboratory Corporation of America Holdings revenue breakdown by business segment: 69.9% from LCD and 30.1% from CDD

Laboratory Corporation of America Holdings Online and Social Media Presence

Laboratory Corporation of America Holdings's Trends

Embed Graph

Laboratory Corporation of America Holdings News and Updates

June 06, 2019

Faruqi & Faruqi, LLP is Investigating Laboratory Corporation of America Holdings (LH) on Behalf of its Shareholders

NEW YORK, June 6, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential misconduct at Laboratory Corporation of America Holdings ("LabCorp" or the "Company") (NYSE:LH). The investigation focuses on whether the Company's Board of...
January 11, 2019

New Study Focusing on Healthcare Contract Research Outsourcing Market by 2023: Competition Status, Emerging Trends, Growth Factors and Key Players Like IQVIA, PRA Health Sciences, Inc., ICON PLC, and Laboratory Corporation of America Holdings, PAREXEL Int

The Healthcare Contract Research Outsourcing Market report provides complete insights of the market by segmenting the market. Posted via Industry Today. Follow us on Twitter @IndustryToday
November 27, 2018

Global Esoteric Testing Market Analysis and Forecasts Report 2018-2025 Featuring Key Players - Laboratory Corporation of America Holdings & Quest Diagnostics Incorporated

DUBLIN, Nov. 27, 2018 /PRNewswire/ -- The "Esoteric Testing Market to 2025 - Global Analysis and Forecasts by Technology, Test Type, End User and Geography" report has been added to ResearchAndMarkets.com's offering. The market is expected to reach US$ $ 45,081.6 Mn in 2025 from US$...

Laboratory Corporation of America Holdings Blogs

September 10, 2020

Labcorp Acquires Clinical Ambulatory Laboratory Business of Franciscan Missionaries of Our Lady Health System

Labcorp Acquires Clinical Ambulatory Laboratory Business of Franciscan Missionaries of Our Lady Health System John.Bissaillo… Thu, 09/10/2020 - 09:42 Labcorp Acquires Clinical Ambulatory Laboratory Business of Franciscan Missionaries of Our Lady Health System Sep 10, 2020 …
September 08, 2020

COVID-19 PCR Testing Time to Result

COVID-19 PCR Testing Time to Result dionc1 Tue, 09/08/2020 - 15:29 https://files.labcorp.com/labcorp-d8/2020-08/hero_1.jpg LabCorp's COVID-19 PCR Testing Time to Result Historical Data Average Weekly Result Delivery Timeframe from Specimen Pickup …
September 08, 2020

LabCorp Launches First Combined Test for COVID-19, Flu and RSV in Time for Flu Season

LabCorp Launches First Combined Test for COVID-19, Flu and RSV in Time for Flu Season dionc1 Tue, 09/08/2020 - 07:32 https://files.labcorp.com/labcorp-d8/2020-08/hero_1.jpg September 8, 2020 | SOURCE: Labcorp LabCorp Launches First Combined Test for COVID-19, Flu and RS…
September 08, 2020

LabCorp Launches First Combined Test for Covid-19, Flu and RSV in Time for Flu Season

LabCorp Launches First Combined Test for Covid-19, Flu and RSV in Time for Flu Season John.Bissaillo… Tue, 09/08/2020 - 07:24 LabCorp Launches First Combined Test for Covid-19, Flu and RSV in Time for Flu Season Sep 08, 2020 This release is a backfill from a …
September 01, 2020

LabCorp Is Scheduled to Present at the Baird’s 2020 Global Healthcare Conference

LabCorp Is Scheduled to Present at the Baird’s 2020 Global Healthcare Conference Ephraim.DeGuia… Tue, 09/01/2020 - 16:23 LabCorp Is Scheduled to Present at the Baird’s 2020 Global Healthcare Conference Sep 01, 2020 This release is a backfill from a News Wire …
August 27, 2020

Women in Leadership - Edna Parker

Women in Leadership - Edna Parker dionc1 Thu, 08/27/2020 - 10:57 Unique perspectives sharpen our thinking Menu Home Home Blog Blog …
Show more

 Laboratory Corporation of America Holdings Frequently Asked Questions

  • When was Laboratory Corporation of America Holdings founded?

    Laboratory Corporation of America Holdings was founded in 1976.

  • Who are Laboratory Corporation of America Holdings key executives?

    Laboratory Corporation of America Holdings's key executives are David P. King, Glenn A. Eisenberg and Lance V. Berberian.

  • How many employees does Laboratory Corporation of America Holdings have?

    Laboratory Corporation of America Holdings has 61,000 employees.

  • What is Laboratory Corporation of America Holdings revenue?

    Latest Laboratory Corporation of America Holdings annual revenue is $11.6 b.

  • What is Laboratory Corporation of America Holdings revenue per employee?

    Latest Laboratory Corporation of America Holdings revenue per employee is $189.4 k.

  • Who are Laboratory Corporation of America Holdings competitors?

    Competitors of Laboratory Corporation of America Holdings include Brooks Automation, Quest Diagnostics and Universal Biosensors.

  • Where is Laboratory Corporation of America Holdings headquarters?

    Laboratory Corporation of America Holdings headquarters is located at 531 S Spring St, Burlington.

  • Where are Laboratory Corporation of America Holdings offices?

    Laboratory Corporation of America Holdings has an office in Burlington.

  • How many offices does Laboratory Corporation of America Holdings have?

    Laboratory Corporation of America Holdings has 1 office.